Back
Bicycle Therapeutics PLC Stock Predictions
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
37
BCYC
Bicycle Therapeutics PLC
Last Price:
$8.96
Seasonality Move:
18.35%
7 Day Trial
ALL ACCESS PASS
$
7
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteBicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 3.2% based on the past 5 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $8.54. The Score for BCYC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 3.2% based on the past 5 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
37
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
6.10
Prediction Charts
Market Cap:
591.4M
Price in USD:
8.54
Volume:
141.1K
Beta:
0.91
Technical Analysis
SMA50:
8.06
SMA100:
9.85
SMA200:
15.72
52-Wk Change:
-62.93%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 8.54 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-20 | 8.70 | 8.51 | 8.73 | 8.47 |
| May-21 | 8.39 | 8.05 | 8.64 | 8.00 |
| May-22 | 7.99 | 8.10 | 8.17 | 7.89 |
| May-23 | 7.96 | 8.05 | 8.10 | 7.91 |
| May-27 | 8.18 | 8.03 | 8.58 | 8.01 |
| May-28 | 8.01 | 8.20 | 8.50 | 8.00 |
| May-29 | 8.31 | 8.70 | 8.73 | 8.15 |
| May-30 | 8.55 | 8.22 | 8.65 | 8.09 |
| Jun-2 | 8.34 | 8.55 | 8.71 | 8.25 |
| Jun-3 | 8.53 | 8.30 | 8.75 | 8.29 |
| Jun-4 | 8.28 | 8.46 | 8.46 | 8.19 |
| Jun-5 | 8.49 | 8.50 | 8.68 | 8.32 |
| Jun-6 | 8.58 | 8.55 | 8.98 | 8.51 |
| Jun-9 | 8.60 | 8.54 | 8.80 | 8.34 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.